Skip to main content

8-K

Xylem Inc. (XYL)

8-K 2020-02-06 For: 2020-02-06
View Original
Added on April 11, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 6, 2020

XYLEM INC.

(Exact name of registrant as specified in its charter)

Indiana 001-35229 45-2080495
(State or other jurisdiction<br><br>of incorporation) (Commission<br><br>File Number) (IRS Employer<br><br>Identification No.) 1 International Drive 10573
--- --- ---
Rye Brook, New York
(Address of principal executive offices) (Zip Code)

(914) 323-5700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange of which registered
Common Stock, par value $0.01 per share XYL New York Stock Exchange
2.250% Senior Notes due 2023 XYL23 New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | | --- | --- || ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | | --- | --- || ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | | --- | --- || ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | | --- | --- || ☐ | Emerging growth company | | --- | --- |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨


Item 2.02 Results of Operations and Financial Condition

On February 6, 2020, Xylem Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit<br><br>No. Description
99.1 Press Release issued by Xylem Inc. on February 6, 2020.
104.0 The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL (included as Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

XYLEM INC.
Date: February 6, 2020 By: /s/ E. Mark Rajkowski
E. Mark Rajkowski
Senior Vice President & Chief Financial Officer<br><br>(Authorized Officer of Registrant)
		Exhibit

Exhibit 99.1

xylemlogoa18.jpg

Xylem Inc.

1 International Drive, Rye Brook N.Y. 10573

Tel +1.914.323.5700 Fax +1.914.323.5752

Contacts: Media Investors
Houston Spencer +1 (914) 323-5723 Matt Latino +1 (914) 323-5821
Houston.Spencer@xyleminc.com Matthew.Latino@xyleminc.com

Xylem reports fourth quarter and full-year 2019 earnings

Full-year 2019 reported net income of $401 million or $2.21 per share; adjusted full-year net income of $547 million or $3.02 per share
Full-year free cash flow conversion was 124%
--- ---
Fourth quarter 2019 reported net income was $118 million or $0.65 per share; adjusted net income of $161 million or $0.89 per share
--- ---
Announces 8% increase in cash dividend, representing the company’s ninth consecutive annual dividend increase
--- ---
Provides 2020 organic revenue growth guidance range of 1% to 3% and adjusted earnings per share range of $2.96 to $3.16
--- ---

RYE BROOK, N.Y., February 6, 2020 - Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported full-year 2019 revenue of $5.25 billion, up one percent on a reported basis and four percent on an organic basis. Full-year reported net income was $401 million, or $2.21 per share, with a reported operating margin of 9.3 percent. Adjusted net income, which excludes the impact of restructuring, realignment and special charges, was $547 million, or $3.02 per share. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) was 19.5 percent, flat year-over-year. Xylem delivered full-year 2019 adjusted operating margin of 13.9 percent, up 20 basis points versus the prior year. The Company generated $613 million in free cash flow, representing a 124 percent conversion.

In the fourth quarter 2019, Xylem generated net income of $118 million, or $0.65 per share, and adjusted net income of $161 million, or $0.89 per share, which excludes the impact of restructuring, realignment and special charges. Fourth quarter revenue was $1.37 billion reflecting ongoing softness in Industrial and Commercial end markets. Adjusted EBITDA declined 10 basis points to 20.5 percent. Reported operating margin in the quarter was 14.2 percent and adjusted operating margin declined 10 basis points year-over-year to 15.0 percent.

“Our teams continued to capitalize on Xylem’s portfolio of industry-leading technologies throughout 2019, again delivering mid-single-digit growth in the Utilities market globally, including double-digit growth in China and India,” said Patrick Decker, president and CEO of Xylem. “However, soft Industrial and Commercial markets in the second half slowed our overall revenue growth and margin progress for the year. In response to those challenges, we effectively contained costs, significantly improved working capital, and exceeded our free cash flow conversion commitments.”


“We’ve entered 2020 with strong operational discipline, solid foundations underpinning continued growth, and an energized global team leading the industry on sustainability,” Decker continued. “We’re confident we can manage through soft conditions persisting through the first half, and we foresee a moderate second-half recovery in our short-cycle businesses in parallel with ramp-ups in several large Utilities projects in our backlog. We expect a return to mid-single-digit growth in the second half of the year.”

Xylem announced that its Board of Directors declared a dividend in the amount of $0.26 per share, an increase of 8 percent. The dividend is payable on March 26, 2020, to shareholders of record as of February 27, 2020.

Full-year 2020 Outlook

Xylem forecasts full-year 2020 organic revenue in the range of $5.3 to $5.35 billion, up one to three percent.

Full-year 2020 adjusted operating margin is expected to be in the range of 14.0 to 14.5 percent, resulting in adjusted earnings per share of $2.96 to $3.16. This represents an increase of one to eight percent from Xylem’s 2019 adjusted results, excluding the impact of foreign exchange translation and a reduction in non-cash pension income. The Company’s adjusted earnings outlook excludes projected restructuring and realignment costs in the range of $35 million to $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Fourth Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Fourth quarter 2019 revenue was $603 million, up one percent organically compared with fourth quarter 2018. This increase was driven by solid results in the Utilities end market in the Emerging Markets and Europe. This was largely offset by declines in its short-cycle industrial dewatering business.
Fourth quarter reported operating income for the segment was $119 million. Adjusted operating income for the segment, which excludes $6 million of restructuring and realignment, was $125 million. Reported operating margin for the Water Infrastructure segment was 19.7 percent, up 20 basis points versus the prior year, and adjusted operating margin was 20.7 percent, flat with prior year. Strong productivity benefits and cost control offset inflation, lower volumes, and unfavorable mix from our high-margin Dewatering business.
--- ---

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

Fourth quarter 2019 Applied Water revenue was $392 million, a two percent decline organically year-over-year. Volume weakness in the Commercial and Industrial end markets continued in the quarter, with particular softness in the United States and Europe, partly offset by modest growth in Emerging Markets.
Fourth quarter reported operating income for the segment was $62 million and adjusted operating income, which excludes $3 million of restructuring and realignment costs, was $65 million, a six percent decrease versus the comparable period last year. The segment reported operating margin was 15.8 percent, down 60 basis points versus the prior year period. Adjusted operating margin declined 60 basis points to 16.6 percent. Strong productivity and price realization in the segment was more than offset by inflation, unfavorable mix, and lower volumes.
--- ---

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

Fourth quarter 2019 Measurement & Control Solutions revenue was $376 million, up two percent organically versus the prior year, driven by higher energy project deployments in the United States, and stronger international water metrology demand.
Fourth quarter reported operating income for the segment was $27 million, and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $29 million. Measurement & Control Solutions segment reported operating margin was 7.2 percent. Adjusted operating margin of 7.7 percent increased 20 basis points over the prior year period. Productivity benefits and price realization offset inflation and mix headwinds to modestly expand margins.
--- ---

Supplemental information on Xylem’s fourth quarter 2019 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s more than 16,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2019 revenue of $5.25 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all - that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include any statements that are not historical in nature, including any statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results - are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.


Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions; geopolitical and other risks associated with our international operations, including military actions, protectionism, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, data privacy, export and import laws and competition laws; actual or potential pandemics; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates;  disruption, competition and pricing pressures in the markets we serve; industrial, governmental and private sector spending; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our supply chain including channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product security, product liability and recalls; claims or investigations by governmental or regulatory bodies; cybersecurity attacks, breaches or other disruptions of information technology systems on which we rely; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 ("2018 Annual Report") and with subsequent filings we make with the Securities and Exchange Commission ("SEC").

All forward-looking statements made herein are based on information currently available to the Company as of the date of this Report.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

Year Ended December 31, 2019 2018 2017
Revenue $ 5,249 $ 5,207 $ 4,707
Cost of revenue 3,203 3,181 2,860
Gross profit 2,046 2,026 1,847
Selling, general and administrative expenses 1,158 1,161 1,089
Research and development expenses 191 189 181
Restructuring and asset impairment charges 63 22 25
Goodwill impairment charge 148
Operating income 486 654 552
Interest expense 67 82 82
Other non-operating (expense) income, net (4 ) 13 6
Gain (loss) on sale of businesses 1 (10 )
Income before taxes 416 585 466
Income tax expense 15 36 136
Net income 401 549 330
Less: Net loss attributable to non-controlling interests (1 )
Net income attributable to Xylem $ 401 $ 549 $ 331
Earnings per share:
Basic $ 2.23 $ 3.05 $ 1.84
Diluted $ 2.21 $ 3.03 $ 1.83
Weighted average number of shares:
Basic 180.0 179.8 179.6
Diluted 181.2 181.1 180.9

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

December 31, 2018
ASSETS
Current assets:
Cash and cash equivalents 724 $ 296
Receivables, less allowances for discounts, returns and doubtful accounts of 35 and 35 in 2019 and 2018, respectively 1,031
Inventories 595
Prepaid and other current assets 172
Total current assets 2,094
Property, plant and equipment, net 656
Goodwill 2,976
Other intangible assets, net 1,232
Other non-current assets 264
Total assets 7,710 $ 7,222
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable 597 $ 586
Accrued and other current liabilities 546
Short-term borrowings and current maturities of long-term debt 257
Total current liabilities 1,389
Long-term debt, net 2,051
Accrued postretirement benefits 400
Deferred income tax liabilities 303
Other non-current accrued liabilities 297
Total liabilities 4,440
Stockholders’ equity:
Common stock — par value 0.01 per share:
Authorized 750.0 shares, issued 193.9 and 192.9 shares in 2019 and 2018, respectively 2
Capital in excess of par value 1,950
Retained earnings 1,639
Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively ) (487 )
Accumulated other comprehensive loss ) (336 )
Total stockholders’ equity 2,768
Non-controlling interest 14
Total equity 2,782
Total liabilities and stockholders’ equity 7,710 $ 7,222

All values are in US Dollars.


XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

Year Ended December 31, 2019 2018 2017
Operating Activities
Net income $ 401 $ 549 $ 330
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 117 117 109
Amortization 140 144 125
Deferred income taxes (77 ) (47 ) (33 )
Share-based compensation 29 30 21
Restructuring and asset impairment charges 63 22 25
Goodwill impairment charge 148
(Gain)/loss from sale of businesses (1 ) 10
Other, net 9 9 19
Payments for restructuring (30 ) (21 ) (28 )
Contributions to postretirement benefit plans (19 ) (41 ) (33 )
Changes in assets and liabilities (net of acquisitions):
Changes in receivables (23 ) (103 ) (79 )
Changes in inventories 47 (97 ) 27
Changes in accounts payable 29 51 50
Changes in accrued liabilities 15 (6 ) 28
Changes in accrued taxes (13 ) 104
Net changes in other assets and liabilities 4 (21 ) 11
Net Cash — Operating activities 839 586 686
Investing Activities
Capital expenditures (226 ) (237 ) (170 )
Proceeds from the sale of property, plant and equipment 1
Acquisitions of businesses and assets, net of cash acquired (18 ) (433 ) (33 )
Proceeds from sale of businesses 22 16
Cash received from investments 11 11 10
Cash paid for investments (7 ) (11 ) (11 )
Cash received from cross currency swaps 9
Other, net 5 6
Net Cash — Investing activities (231 ) (643 ) (181 )
Financing Activities
Short-term debt issued, net 281 335
Short-term debt repaid, net (254 ) (52 ) (282 )
Long-term debt issued, net 1
Long-term debt repaid, net (120 )
Repurchase of common stock (40 ) (59 ) (25 )
Proceeds from exercise of employee stock options 13 7 16
Dividends paid (174 ) (152 ) (130 )
Other, net (3 )
Net Cash — Financing activities (177 ) (40 ) (421 )
Effect of exchange rate changes on cash (3 ) (21 ) 22
Net change in cash and cash equivalents 428 (118 ) 106
Cash and cash equivalents at beginning of year 296 414 308
Cash and cash equivalents at end of year $ 724 $ 296 $ 414
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest $ 77 $ 78 $ 78
Income taxes (net of refunds received) $ 107 $ 75 $ 57

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent non-GAAP measures as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of "free cash flow" does not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Sensus Acquisition Related Costs"defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs not included in "Sensus Acquisition Related Costs", non-cash impairment charges and other special non-operating items, such as pension adjustments.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Orders

($ Millions)

(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E)=B+C+D (F) = E/A (G) = (E - C) / A
Orders Orders Change 2019 v. 2018 % Change 2019 v. 2018 Acquisitions/<br>Divestitures FX<br>Impact Change<br>Adj.<br>2019 v. 2018 % Change<br>Adj. 2019 v. 2018
2019 2018
Year Ended December 31
Xylem Inc. 5,339 5,437 (98 ) -2 % 17 129 48 1 % 1 %
Water Infrastructure 2,234 2,255 (21 ) -1 % 74 53 2 % 2 %
Applied Water 1,556 1,557 (1 ) 0 % 29 28 2 % 2 %
Measurement & Control Solutions 1,549 1,625 (76 ) -5 % 17 26 (33 ) -2 % -3 %
Quarter Ended December 31
Xylem Inc. 1,286 1,383 (97 ) -7 % 4 16 (77 ) -6 % -6 %
Water Infrastructure 530 584 (54 ) -9 % 10 (44 ) -8 % -8 %
Applied Water 387 395 (8 ) -2 % 3 (5 ) -1 % -1 %
Measurement & Control Solutions 369 404 (35 ) -9 % 4 3 (28 ) -7 % -8 %
Quarter Ended September 30
Xylem Inc. 1,346 1,356 (10 ) -1 % 4 24 18 1 % 1 %
Water Infrastructure 586 537 49 9 % 13 62 12 % 12 %
Applied Water 376 377 (1 ) 0 % 6 5 1 % 1 %
Measurement & Control Solutions 384 442 (58 ) -13 % 4 5 (49 ) -11 % -12 %
Quarter Ended June 30
Xylem Inc. 1,392 1,378 14 1 % 7 33 54 4 % 3 %
Water Infrastructure 586 580 6 1 % 16 22 4 % 4 %
Applied Water 399 401 (2 ) 0 % 8 6 1 % 1 %
Measurement & Control Solutions 407 397 10 3 % 7 9 26 7 % 5 %
Quarter Ended March 31
Xylem Inc. 1,315 1,320 (5 ) 0 % 2 56 53 4 % 4 %
Water Infrastructure 532 554 (22 ) -4 % 35 13 2 % 2 %
Applied Water 394 384 10 3 % 12 22 6 % 6 %
Measurement & Control Solutions 389 382 7 2 % 2 9 18 5 % 4 %

Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Revenue

($ Millions)

(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Revenue Revenue Change 2019 v. 2018 % Change 2019 v. 2018 Acquisitions/<br>Divestitures FX<br>Impact Change<br>Adj.<br>2019 v. 2018 % Change<br>Adj. 2019 v. 2018
2019 2018
Year Ended December 31
Xylem Inc. 5,249 5,207 42 1 % 22 124 188 4 % 3 %
Water Infrastructure 2,177 2,176 1 0 % 70 71 3 % 3 %
Applied Water 1,541 1,534 7 0 % 29 36 2 % 2 %
Measurement & Control Solutions 1,531 1,497 34 2 % 22 25 81 5 % 4 %
Quarter Ended December 31
Xylem Inc. 1,371 1,386 (15 ) -1 % 4 17 6 0 % 0 %
Water Infrastructure 603 609 (6 ) -1 % 11 5 1 % 1 %
Applied Water 392 402 (10 ) -2 % 3 (7 ) -2 % -2 %
Measurement & Control Solutions 376 375 1 0 % 4 3 8 2 % 1 %
Quarter Ended September 30
Xylem Inc. 1,296 1,287 9 1 % 4 24 37 3 % 3 %
Water Infrastructure 531 541 (10 ) -2 % 13 3 1 % 1 %
Applied Water 376 378 (2 ) -1 % 6 4 1 % 1 %
Measurement & Control Solutions 389 368 21 6 % 4 5 30 8 % 7 %
Quarter Ended June 30
Xylem Inc. 1,345 1,317 28 2 % 9 32 69 5 % 5 %
Water Infrastructure 561 546 15 3 % 16 31 6 % 6 %
Applied Water 394 388 6 2 % 8 14 4 % 4 %
Measurement & Control Solutions 390 383 7 2 % 9 8 24 6 % 4 %
Quarter Ended March 31
Xylem Inc. 1,237 1,217 20 2 % 5 51 76 6 % 6 %
Water Infrastructure 482 480 2 0 % 30 32 7 % 7 %
Applied Water 379 366 13 4 % 12 25 7 % 7 %
Measurement & Control Solutions 376 371 5 1 % 5 9 19 5 % 4 %

Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

Q1 Q2 Q3 Q4 YTD
2019 2018 2019 2018 2019 2018 2019 2018 2019 2018
Total Revenue
• Total Xylem 1,237 1,217 1,345 1,317 1,296 1,287 1,371 1,386 5,249 5,207
• Water Infrastructure 482 480 561 546 531 541 603 609 2,177 2,176
• Applied Water 379 366 394 388 376 378 392 402 1,541 1,534
• Measurement & Control Solutions 376 371 390 383 389 368 376 375 1,531 1,497
Operating Income
• Total Xylem 109 113 171 171 11 176 195 194 486 654
• Water Infrastructure 51 49 98 92 97 99 119 119 365 359
• Applied Water 56 50 62 61 61 59 62 66 241 236
• Measurement & Control Solutions 16 33 26 31 (136 ) 31 27 23 (67 ) 118
• Total Segments 123 132 186 184 22 189 208 208 539 713
Operating Margin
• Total Xylem 8.8 % 9.3 % 12.7 % 13.0 % 0.8 % 13.7 % 14.2 % 14.0 % 9.3 % 12.6 %
• Water Infrastructure 10.6 % 10.2 % 17.5 % 16.8 % 18.3 % 18.3 % 19.7 % 19.5 % 16.8 % 16.5 %
• Applied Water 14.8 % 13.7 % 15.7 % 15.7 % 16.2 % 15.6 % 15.8 % 16.4 % 15.6 % 15.4 %
• Measurement & Control Solutions 4.3 % 8.9 % 6.7 % 8.1 % (35.0 )% 8.4 % 7.2 % 6.1 % (4.4 )% 7.9 %
• Total Segments 9.9 % 10.8 % 13.8 % 14.0 % 1.7 % 14.7 % 15.2 % 15.0 % 10.3 % 13.7 %
Special Charges
• Total Xylem 4 6 1 155 1 4 159 12
• Water Infrastructure 2 2
• Applied Water
• Measurement & Control Solutions 4 2 1 155 2 159 5
• Total Segments 4 2 1 155 4 159 7
Restructuring & Realignment Costs
• Total Xylem 20 16 21 10 30 11 11 11 82 48
• Water Infrastructure 9 5 9 5 7 5 6 5 31 20
• Applied Water 3 3 4 2 3 2 3 3 13 10
• Measurement & Control Solutions 8 8 8 3 20 4 2 3 38 18
• Total Segments 20 16 21 10 30 11 11 11 82 48
Adjusted Operating Income
• Total Xylem 133 135 192 182 196 188 206 209 727 714
• Water Infrastructure 60 54 107 97 104 104 125 126 396 381
• Applied Water 59 53 66 63 64 61 65 69 254 246
• Measurement & Control Solutions 28 43 34 35 39 35 29 28 130 141
• Total Segments 147 150 207 195 207 200 219 223 780 768
Adjusted Operating Margin
• Total Xylem 10.8 % 11.1 % 14.3 % 13.8 % 15.1 % 14.6 % 15.0 % 15.1 % 13.9 % 13.7 %
• Water Infrastructure 12.4 % 11.3 % 19.1 % 17.8 % 19.6 % 19.2 % 20.7 % 20.7 % 18.2 % 17.5 %
• Applied Water 15.6 % 14.5 % 16.8 % 16.2 % 17.0 % 16.1 % 16.6 % 17.2 % 16.5 % 16.0 %
• Measurement & Control Solutions 7.4 % 11.6 % 8.7 % 9.1 % 10.0 % 9.5 % 7.7 % 7.5 % 8.5 % 9.4 %
• Total Segments 11.9 % 12.3 % 15.4 % 14.8 % 16.0 % 15.5 % 16.0 % 16.1 % 14.9 % 14.7 %

Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

($ Millions, except per share amounts)

Q4 2019 Q4 2018
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue 1,371 1,371 1,386 1,386
Operating Income 195 11 a 206 194 15 a 209
Operating Margin 14.2 % 15.0 % 14.0 % 15.1 %
Interest Expense (15 ) (15 ) (19 ) (19 )
Other Non-Operating Income (Expense) (2 ) 8 b 6 4 1 5
Gain/(Loss) from sale of businesses
Income before Taxes 178 19 197 179 16 195
Provision for Income Taxes (60 ) 24 c (36 ) 46 (82 ) c (36 )
Net Income attributable to Xylem 118 43 161 225 (66 ) 159
Diluted Shares 181.2 181.2 181.0 181.0
Diluted EPS $ 0.65 $ 0.24 $ 0.89 $ 1.24 $ (0.36 ) $ 0.88 Year-over-year currency translation impact on current year diluted EPS $ (0.02 ) $ $ (0.02 )
--- --- --- --- --- --- --- --- ---
Diluted EPS at Constant Currency $ 0.67 $ 0.24 $ 0.91
Q4 YTD 2019 Q4 YTD 2018
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue 5,249 5,249 5,207 5,207
Operating Income 486 241 a 727 654 60 a 714
Operating Margin 9.3 % 13.9 % 12.6 % 13.7 %
Interest Expense (67 ) (67 ) (82 ) (82 )
Other Non-Operating Income (Expense) (4 ) 19 b 15 13 1 14
Gain/(Loss) from sale of businesses 1 (1 )
Income before Taxes 416 259 675 585 61 646
Provision for Income Taxes (15 ) (113 ) c (128 ) (36 ) (88 ) c (124 )
Net Income attributable to Xylem 401 146 547 549 (27 ) 522
Diluted Shares 181.2 181.2 181.1 181.1
Diluted EPS $ 2.21 $ 0.81 $ 3.02 $ 3.03 $ (0.15 ) $ 2.88 Year-over-year currency translation impact on current year diluted EPS $ (0.09 ) $ (0.02 ) $ (0.11 )
--- --- --- --- --- --- --- --- --- ---
Diluted EPS at Constant Currency $ 2.30 $ 0.83 $ 3.13 a Quarter: Restructuring & realignment costs of $11 million in both 2019 and 2018 and special charges of $4 million in 2018 ($2 million of acquisition related costs and $2 million of asset impairment).
--- ---
Year-to-date: Restructuring & realignment costs of $82 million and $48 million in 2019 and 2018, respectively; special charges of $155 million of intangible asset and goodwill impairment and $4 million of acquisition related costs in 2019 and $10 million of acquisition related costs and $2 million of asset impairment costs in 2018.
b Special charges related to incremental pension costs as a result of the planned buyout of our UK pension plan of $6 million for the fourth quarter and $17 million year-to-date and $2 million of other special charges.
c Quarter: Net tax impact on restructuring & realignment costs of $2 million in both 2019 and 2018; $4 million of tax impact on special charges in 2019 and tax-related special items of $30 million positive impact from expense adjustments in 2019 and and $80 million negative impact from benefit adjustments in 2018.
Year-to-date: Net tax impact on restructuring & realignment costs of $19 million and $12 million in 2019 and 2018, respectively; $6 million and $1 million of tax impact on special charges in 2019 and 2018, respectively and tax-related special items of $88 million and $75 million negative impact from benefit adjustments in 2019 and 2018, respectively.

Xylem Inc. Non-GAAP Reconciliation

Net Cash - Operating Activities vs. Free Cash Flow

($ Millions)

Q1 Q2 Q3 Q4 Year Ended
2019 2018 2019 2018 2019 2018 2019 2018 2019 2018
Net Cash - Operating Activities $ 83 $ 63 $ 123 $ 138 $ 245 $ 187 $ 388 $ 198 $ 839 $ 586
Capital Expenditures (69 ) (61 ) (60 ) (50 ) (46 ) (60 ) (51 ) (66 ) (226 ) (237 )
Free Cash Flow $ 14 $ 2 $ 63 $ 88 $ 199 $ 127 $ 337 $ 132 $ 613 $ 349
Cash paid for Sensus acquisition related costs (1 ) (1 )
Free Cash Flow, excluding Sensus Acquisition Related Costs $ 14 $ 3 $ 63 $ 88 $ 199 $ 127 $ 337 $ 132 $ 613 $ 350
Net Income 79 79 139 115 65 130 118 225 401 549
Gain/(Loss) from sale of businesses 1 (2 ) 2 1
Special Charges - non-cash impairment (3 ) (155 ) (2 ) (158 ) (2 )
Significant deferred tax benefit/(charge) 97 (33 ) 84 64 84
Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items $ 81 $ 79 $ 139 $ 117 $ 123 $ 128 $ 151 $ 143 $ 494 $ 467
Free Cash Flow Conversion 17 % 4 % 45 % 75 % 162 % 99 % 223 % 92 % 124 % 75 %

Xylem Inc. Non-GAAP Reconciliation

EBITDA and Adjusted EBITDA by Quarter

($ Millions)

2019
Q1 Q2 Q3 Q4 Total
Net Income 79 139 65 118 401
Income Tax Expense 15 17 (77 ) 60 15
Interest Expense (Income), net 17 18 14 13 62
Depreciation 29 29 30 29 117
Amortization 35 34 35 36 140
EBITDA 175 237 67 256 735
Share-based Compensation 9 7 7 6 29
Restructuring & Realignment 20 21 30 11 82
Loss/(Gain) from sale of business (1 ) (1 )
Special Charges 4 166 8 178
Adjusted EBITDA 207 265 270 281 1,023
Revenue 1,237 1,345 1,296 1,371 5,249
Adjusted EBITDA Margin 16.7 % 19.7 % 20.8 % 20.5 % 19.5 %
2018
Q1 Q2 Q3 Q4 Total
Net Income 79 115 130 225 549
Income Tax Expense 16 35 31 (46 ) 36
Interest Expense (Income), net 20 20 20 18 78
Depreciation 29 29 29 30 117
Amortization 38 36 34 36 144
EBITDA 182 235 244 263 924
Share-based Compensation 9 7 7 7 30
Restructuring & Realignment 16 9 11 11 47
Loss/(Gain) from sale of business 2 (2 )
Special Charges 6 1 1 4 12
Adjusted EBITDA 213 254 261 285 1,013
Revenue 1,217 1,317 1,287 1,386 5,207
Adjusted EBITDA Margin 17.5 % 19.3 % 20.3 % 20.6 % 19.5 %